Case report: ofloxacin-induced hypersensitivity vasculitis

R Pipek1, S Vulfsons, E Wolfovitz

  • 1Department of Internal Medicine D, Rambam Medical Center, Haifa, Israel.

Insights

A rare case of hypersensitivity vasculitis linked to the antibiotic ofloxacin is presented. This severe reaction in a patient

Area of Science:

  • Pharmacology and Toxicology
  • Dermatology
  • Rheumatology

Background:

  • Ofloxacin, a widely used fluoroquinolone antibiotic since 1985, has a known profile of potential adverse effects.
  • While uncommon, skin reactions have been documented with ofloxacin use.
  • Hypersensitivity vasculitis is a rare but serious adverse drug reaction.

Observation:

  • This report details a specific case of a patient experiencing severe vasculitis.
  • The vasculitis affected both legs, necessitating significant medical intervention.
  • The condition was directly attributed to the use of ofloxacin.

Findings:

  • A direct causal link between ofloxacin and hypersensitivity vasculitis was established in this patient.
  • The severity of the vasculitis required advanced treatment, including plastic surgery.
  • This case highlights a rare but critical adverse effect of ofloxacin.

Implications:

  • Clinicians should be aware of the potential for ofloxacin-induced hypersensitivity vasculitis, even if rare.
  • Early recognition and diagnosis are crucial for managing severe cutaneous drug reactions.
  • This case underscores the importance of monitoring patients for unusual adverse events associated with common antibiotics.

Related Concept Videos

Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...